TGFB2 and esophageal cancer: It is reported that imperatorin was verified as a novel TGFB2 inhibitor that can inhibit TGFB2 expression to suppress esophageal cancer metastasis [36], which also inhibited TGFB2 expression in PDAC gemcitabine-resistant cells (Fig. S9(c)).